Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar Dart65GTConv (< 20) Submitted: 5/23/2008 8:05:00 AM : Outperform Start Price: $8.05 OMPI Score: +59.31

NO DEPT "Dept free way to be."

Featured Broker Partners


Advertisement